Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Use of the Predictive Risk Model, LungFlag™ for Lung Cancer Screening in a Spanish Reference Center: A Cost-effectiveness Analysis.

Share this article:

Share your details and we'll email you our Publication

Authors:

María Eugenia Olmedo, Luis Gorospe, Luis Miguel Seijo, Virginia Pajares, Mercè Marzo, Joan B. Soriano, Juan Carlos Trujillo, Natalia Arrabal, Andrés Flores, Fran García, María Crespo, David Carcedo, Carolina Heuser, Olghi Nicolò, Eran Choman, Oliver Higuera

BACKGROUND

Several risk prediction models have been developed to select high-risk individuals for lung cancer screening. These allow the calculation of personalized risk as an alternative to standard criteria based on age and cumulative smoking exposure.

  • LungFlag™ is an artificial intelligence-based risk prediction model effective in the selection of high-risk individuals by evaluating routine clinical and laboratory. 
  • In Spain, there is no national lung cancer screening program, and only a few pilot programs have been developed.
  • The aim of this analysis is to assess the cost-effectiveness of LungFlag for the identification of high-risk individuals for enrolment in a NSCLC screening programme in a hypothetical Spanish reference center.

Conclusions

The implementation of LungFlag as a risk model for NSCLC screening in a hypothetical Spanish reference center would be cost-effective compared to no-screening for the 2 hypothetical cohorts analyzed, providing savings and a higher clinical benefit. Narrowing the screening to patients who meet USPSTF criteria seems to optimise the benefits of using LungFlag.